# Behavioral Predictors of Intentional and Unintentional Nonadherence to Antiretroviral Therapy and Their Implications for Virological Failure Among People with HIV in Taiwan

## TL;DR

This study explores why people with HIV in Taiwan miss their HIV medication, finding that intentional and unintentional nonadherence have different causes and impacts on treatment success.

## Contribution

The study differentiates intentional and unintentional nonadherence in an Asian population and identifies specific behavioral predictors linked to virological failure.

## Key findings

- Recreational drug use and younger age are linked to both intentional and unintentional nonadherence.
- Higher income and single-tablet regimens protect against intentional nonadherence.
- Intentional nonadherence is more strongly associated with virological failure than unintentional nonadherence.

## Abstract

Adherence to antiretroviral therapy (ART) is critical for HIV management and sustained virological suppression. Differentiating intentional from unintentional nonadherence is essential for developing tailored interventions, yet evidence from Asian populations remains limited. A cross-sectional study of 846 people with HIV (PWH) in northern Taiwan assessed ART adherence using the MARS-5 scale. Participants were categorized into good, unintentional, or intentional non-adherence groups. Logistic regression identified associated behavioral and psychosocial factors. Recreational drug use and younger age were independently linked to both unintentional and intentional poor adherence. Higher income and the use of single-tablet regimens were protective against intentional nonadherence, whereas disclosure of HIV status to a partner and an unsuppressed viral load were significantly associated with intentional nonadherence. Reported reasons included being too busy, emotional distress, and running out of medication. These findings suggest that intentional and unintentional nonadherence represent distinct behavioral patterns, with intentional lapses more strongly linked to virological failure. Addressing substance use, simplifying regimens, and providing psychosocial support after disclosure are essential to optimize adherence and achieve UNAIDS 2030 targets.